Carrick Therapeutics website screenshot

Carrick Therapeutics

Carrick Therapeutics is a clinical-stage biopharmaceutical company headquartered in Boston, Massachusetts, developing novel oncology therapies aimed at improving outcomes for patients with aggressive and treatment-resistant cancers. Its pipeline centers on transcriptional CDK inhibition, led by samuraciclib (a CDK7 inhibitor in Phase 2) and CT7439 (a CDK12/13 inhibitor in Phase 1), pursued as combination therapies across advanced hormone-receptor-positive/HER2-negative breast cancer, prostate cancer, ovarian cancer, and additional indications. The company is backed by GV (Google Ventures) and was added to the API Evangelist network as a life-sciences company profile; it publishes no developer API, SDK, or documentation surface at this time.

Carrick Therapeutics is profiled on the APIs.io network. Tagged areas include Company, Life Sciences, Biotechnology, Pharmaceuticals, and Oncology.

Carrick Therapeutics’ developer surface includes engineering blog and 3 more developer resources.

🌐 Visit website 📡 Source on GitHub
11.2/100 minimal ▬ flat Agent 0/100 human only Full breakdown ↓
scored 2026-07-27 · rubric v0.5
0 APIs
CompanyLife SciencesBiotechnologyPharmaceuticalsOncologyClinical StageDrug Development

Kin Score

Kin Score Kin Score How this is scored →
scored 2026-07-27 · rubric v0.5
Composite quality — 11.2/100 · minimal
Contract Quality 0.0 / 25
Developer Ergonomics 0.4 / 20
Commercial Clarity 2.1 / 20
Operational Transparency 0.0 / 13
Governance 0.0 / 12
Discoverability 6.8 / 10
Agent readiness — 0/100 · human only
Machine-Readable Contract 0 / 18
Agentic Access Contract 0 / 15
MCP Server 0 / 12
Machine-Readable Auth 0 / 10
Idempotency 0 / 9
Stable Error Semantics 0 / 8
Request/Response Examples 0 / 7
Rate-Limit Signaling 0 / 7
Typed Event Surface 0 / 6
Agent Skills 0 / 5
Well-Known Catalog 0 / 4
Consent & Bot Identity 0 / 3
Improve this rating by publishing the missing artifacts — every area above can be raised, and the full rubric is at apis.io/rating/. This rating is computed from github.com/api-evangelist/carrick-therapeutics: open an issue to ask a question, or submit a pull request to add artifacts. Want it done for you? Prioritized profiling — $2,500 →

Security Posture 1

Authentication, domain security, vulnerability disclosure, and trust-center signals.

Carrick Therapeutics Domain Security

TLSv1.3 · HSTS

SECURITY

Resources

Access & Security 1

Authentication, authorization, and security posture

DomainSecurity
DomainSecurity

Commercial 1

Pricing, plans, and the legal terms of use

PrivacyPolicy
PrivacyPolicy

Company 2

The organization behind the API

Website
Website
 Blog
Blog

Source (apis.yml)

apis.yml Raw ↑ 
aid: carrick-therapeutics
accessModel:
  pricing: unknown
  onboarding: unknown
  trial: false
  try_now: false
  public: false
  label: Unknown
  confidence: low
  source: []
  generated: '2026-07-22'
  method: derived
image: https://kinlane-images.s3.amazonaws.com/shared/apis-json/icons/carrick-therapeutics.png
name: Carrick Therapeutics
description: Carrick Therapeutics is a clinical-stage biopharmaceutical company headquartered in Boston, Massachusetts, developing
  novel oncology therapies aimed at improving outcomes for patients with aggressive and treatment-resistant cancers. Its pipeline
  centers on transcriptional CDK inhibition, led by samuraciclib (a CDK7 inhibitor in Phase 2) and CT7439 (a CDK12/13 inhibitor
  in Phase 1), pursued as combination therapies across advanced hormone-receptor-positive/HER2-negative breast cancer, prostate
  cancer, ovarian cancer, and additional indications. The company is backed by GV (Google Ventures) and was added to the API
  Evangelist network as a life-sciences company profile; it publishes no developer API, SDK, or documentation surface at this
  time.
url: https://raw.githubusercontent.com/api-evangelist/carrick-therapeutics/refs/heads/main/apis.yml
x-type: company
x-source: vc-portfolio
x-backed-by:
- gv
x-tier: stub
x-tier-reason: portfolio-lead
specificationVersion: '0.20'
created: '2026-07-17'
modified: '2026-07-18'
tags:
- Company
- Life Sciences
- Biotechnology
- Pharmaceuticals
- Oncology
- Clinical Stage
- Drug Development
apis: []
maintainers:
- FN: Kin Lane
  email: kin@apievangelist.com
- FN: APIs.json
  email: info@apis.io
common:
- type: DomainSecurity
  url: security/carrick-therapeutics-domain-security.yml
- type: Website
  url: https://www.carricktherapeutics.com
- type: Blog
  url: https://www.carricktherapeutics.com/news-media/press-releases
- type: PrivacyPolicy
  url: https://www.carricktherapeutics.com/privacy-policy
x-enrichment:
  date: '2026-07-19'
  status: backfilled
  pass: local-v1
  note: backfilled from .gitignore signal + verified work evidence